Business Context and Reporting Period
This Form 8-K is a current report filed by Oncocyte Corporation (trading symbol: OCX) on September 14, 2023. The filing discloses the entry into a Material Definitive Agreement regarding a sublease of corporate office space located at 15 Cushing, Irvine, California.
Key Financial Metrics and Agreement Terms
The filing details a Sublease Agreement with Induce Biologics USA, Inc. ("Subtenant") for approximately 13,400 square feet of rentable space, with an option to expand to the full 26,800 square feet of the premises.
- Security Deposit: $101,987.38 paid by the Subtenant.
- Initial Period Rent: $36,850.00 per month (commencing 120 days after the effective date through December 31, 2024).
- Expansion Period Rent: Ranges from $75,844.00 to $80,533.98 per month depending on the year, covering the period from July 2025 through October 31, 2027.
- Expense Allocation: During the Initial Period, the Subtenant is responsible for 50% of Expenses and Taxes; thereafter, the Subtenant assumes full responsibility for Additional Rent.
Material Changes
The primary material change is the execution of the Sublease Agreement, effective September 14, 2023, following Landlord consent. This agreement alters the Company's occupancy costs and generates new rental income streams. The filing does not provide comparative financial data for prior periods as it is a disclosure of a specific contractual event rather than a periodic financial report.
Outlook, Risks, and Contingencies
The agreement includes a one-time option for the Subtenant to accelerate the Expansion Date with 90 days' prior written notice. The Company retains the right to terminate the Sublease Agreement and retake the premises if the Subtenant fails to remedy defaults within specified time periods. The filing notes that the description of terms is qualified by reference to the full text of the agreement, which will be filed as an exhibit to the Form 10-Q for the quarter ending September 30, 2023.
Investor Verification Checklist
- Verify the exact Commencement Date (120 days post-effective date) to confirm the start of rental income recognition.
- Review the full Sublease Agreement (Exhibit to the upcoming 10-Q) for detailed definitions of "Expenses" and "Taxes."
- Monitor the Subtenant's financial stability to assess the risk of default and potential termination of the sublease.
- Confirm the impact of the 50% expense allocation during the Initial Period on the Company's net operating income.